AI Accelerates the Discovery of High-Affinity Antibodies

An artificial intelligence (AI)-based method for finding high-affinity antibody drugs has been formulated by a team of researchers at the University of California San Diego School of Medicine.

Related Keywords

California ,United States ,San Diego ,University Of California San Diego ,Jonathan Parkinson ,Skyla Baily ,University Of California ,Nature Communications ,School Of Medicine ,Uc San Diego Health Sciences ,National Institutes Of Health Grant Nos ,Drug Administration ,California San Diego School ,Study Senior Author ,Molecular Medicine ,Ryan Hard ,National Institutes ,Grant Nos ,